title: [Asthma therapy for adults].
abstract: The goal of asthma management is to achieve control of the condition. This essentially requires environmental control measures (allergen avoidance) and patient training and education. Drug treatment comprises anti-inflammatory (corticosteroids), and bronchodilatory controller therapy (long-acting beta 2-sympathomimetics, leukotriene receptor antagonists, retarded theophylline) as well as bronchodilatory medication as required (short-acting beta 2-sympathomimetics). The number and frequency of pharmacologic therapy relates to the severity of the clinical presentation. The combination of certain controller drugs (corticosteroids with long-acting beta 2-agonists, corticosteroids with leukotriene receptor antagonists, and beta 2-agonists with leukotriene receptor antagonists) yields a synergistic therapeutic effect as well as a compliance advantage.
authors.affiliation: Medizinische Klinik IV, Pneumologie & Allergologie, Friedrich-Schiller-Universität Jena. claus.kroegel@med.uni-jena.de
authors.forename: C
authors.initials: C
authors.lastname: Kroegel
authors.forename: B
authors.initials: B
authors.lastname: Mock
authors.forename: A
authors.initials: A
authors.lastname: Reissig
authors.forename: U
authors.initials: U
authors.lastname: Hengst
authors.forename: A
authors.initials: A
authors.lastname: Machnik
authors.forename: M
authors.initials: M
authors.lastname: Henzgen
mesh_terms: D000328:Adult; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D001249:Asthma / Q000503:physiopathology / Q000628:therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006801:Humans
chemical_list: D018927:Anti-Asthmatic Agents; D001993:Bronchodilator Agents
vernacular_title: Therapie des Asthma bronchiale im Erwachsenenalter.